Your Article Summary
See Latest ArticlesLimiting the Morbidity of Inguinal Lymphadenectomy for Metastatic Melanoma
Cancer Control, 06/30/09
Sarnaik AA et al. - The morbidity of inguinal lymphadenectomy can be substantial, several straightforwardpre- and postoperative measures can be instituted to limit morbidity. Controversy persists regarding the indicationsfor and benefit of pelvic lymphadenectomy, saphenous vein preservation, and sartorius muscle transposition. A multi-institutional trial is currently in progress to investigate the safety of avoiding lymphadenectomy in patients with microscopic metastases in the sentinel node.
Related Articles
Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy
The Oncologist, 10/30/09
Relevance Score: 70%
Loss of SNF5 expression correlates with poor patient survival in melanoma
Clinical Cancer Research, 10/12/09
Relevance Score: 70%
Results of a multicenter, randomized, double-blind phase 2/3 study of lenalidomide in the treatment of pretreated relapsed or refractory metastatic malignant melanoma
Cancer, 10/30/09
Relevance Score: 69%
Dormancy of metastatic melanoma
Pigment Cell & Melanoma Research, 11/11/09
Relevance Score: 68%
Metastatic cutaneous malignant melanoma: Spectrum of imaging findings and the role of multimodality imaging
Journal of Medical Imaging and Radiation Oncology (JMIRO), 10/05/09
Relevance Score: 68%
Today in Dermatologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
High-dose-rate (HDR) plesiotherapy with custom-made moulds for the treatment of non-melanoma skin cancer
Clinical and Translational Oncology, 12/14/09
Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin
The Journal of Pathology, 12/12/09
Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma
Clinical Cancer Research, 12/12/09